The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Joint BAP NAPICU Rapid Tranquillisation Guidelines Meeting8th June 2018, Hallam Street Conference Centre, London
Visualising Psychotropic Medicine (VPM)Presenting what can be a complex set of data in a useful and engaging way
BAP 2018 Programme at a glanceDownload the summary programme for this year's Summer Meeting in London
Summer Meeting 2018Join us in London 22nd to 25th July 2018
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|8th June 2018||Joint BAP NAPICU evidence based guidelines for the clinical management of acute disturbance (de-escalation and rapid tranquillisation)||Council Chamber, Hallam Street Conference Centre, 44 Hallam St, Marylebone, London|
|16th June 2018||CINP 31st World Congress||Vienna|
|24th June 2018||ECNP School of Neuropsychopharmacology||St Catherine's College, Oxford|
Street Drugs in the Northern Powerhouse: Perspective and Policy
By Jo Neill
Posted on 9th April 2018
Launch of The BAP President’s Symposium Jo Neill, BAP President and Professor of Psychopharmacology at UoM, April 2018 Photos by Russell Bloor and Keith Nuttall On 28th March on an “almost sunny” day in Manchester, world experts in the field of substance misuse gathered for a ground breaking and unique event, a one day public […]
Journal of Psychopharmacology and Therapeutic Advances in Psychopharmacology
Posted on 18th December 2017
Open Access A large number of new gold open access (OA) journals have been launched in recent years to provide immediate open access to research at the point of publication. It is estimated that 16% of peer reviewed journals are now gold OA. These use funding models that do not charge the reader or institution […]
How functional neuroimaging is informing cognitive neurobiological models of auditory verbal hallucinations
By Thomas Dunne
Posted on 11th October 2017
Introduction Auditory verbal hallucinations (AVHs), or “hearing voices”, are a complex phenomenon characterised by abnormal perceptions of speech occurring in the absence of an appropriate external stimulus.1 Hallucinations of this modality hold great diagnostic significance, with Schneider’s (1959) first-rank symptoms of schizophrenia (including AVHs) still recognised today by major classification systems such as the International […]
The Guardian: This revolution in our understanding of depression will be life-transforming
Ed wrote an article for The Guardian about the genetics of depression.
29th April 2018
Improving opioid painkillers: can they be made safer?
Antonio (along with Sera Moore, Jade Morgan, and Joe Chadwick) was involved in the development of an informative video on novel, low-abuse analgesics and accompanying questionnaire.
13th April 2018
The Guardian: Why science is being more open about animals in research
Sarah wrote an article for the Guardian about animal research and openness.
6th April 2018
Analysing Stan: Psychologists reveal what Eminem's hit track really means
Akeem and Becky explain what Eminem’s ill-fated fictional superfan can tell us about the brain and mental health.
5th March 2018
TEDx: Would there be mental illness in a utopia?
Liz did a TEDx talk about imagining a world without mental illness
23rd February 2018
|Alzheimer’s researchers win world’s top brain research prize |
6th March 2018
Four neuroscientists working in the UK, Belgium and Germany have today (6 March) won the world’s most valuable prize for brain research
|Human Brain Project SP8 Open Calls now published |
8th February 2018
Calls for Expression of Interest for SGA2 are no open
|BAP launches the President's biennial symposium |
4th January 2018
BAP invites you to rethink street drugs and explore their use in the medical setting.
|Professor Carmine Pariante awarded Distinguished Investigator Grant |
15th December 2017
BAP Council Member Prof Carmine Pariante (IoPPN), awarded a Distinguished Investigator Grant by the Brain & Behavior Research Foundation
Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.